The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.
Standard cost-effectiveness analysis (CEA) answers one question: does this intervention generate more health per pound spent than the alternatives? It aggregates health across all patients as if a QALY gained by the most deprived person equals a QALY gained by the least deprived.
This approach is silent on who benefits — and therefore on how interventions affect health inequalities between socioeconomic groups.
Distributional Cost-Effectiveness Analysis (DCEA), developed by Cookson, Griffin, Norheim and Culyer (2020), extends standard CEA by:
| Method | When to use | Data required |
|---|---|---|
| Aggregate DCEA | Standard TA; disease-level HES data available | ICER, incremental QALY/cost, disease ICD |
| Full-form DCEA | Subgroup trial data available; HST or exceptional case | Per-group QALY/cost estimates |
NICE (2025) recommends aggregate DCEA as the default supplementary analysis for technology appraisals where equity is relevant.
result <- run_aggregate_dcea(
icer = 28000,
inc_qaly = 0.45,
inc_cost = 12600,
population_size = 12000,
wtp = 20000,
opportunity_cost_threshold = 13000
)
summary(result)
#> == Aggregate DCEA Result ==
#> ICER: £28,000 / QALY
#> Incremental QALY: 0.4500
#> Incremental cost: £12,600
#> Population size: 12,000
#> Net Health Benefit: -6230.77 QALYs
#> SII change: 0.0000
#> Decision: Lose-Lose (efficiency loss + equity loss)
#>
#> -- Per-group results --
#> # A tibble: 5 × 4
#> group_label baseline_hale post_hale nhb
#> <chr> <dbl> <dbl> <dbl>
#> 1 Q1 (most deprived) 52.1 52.0 -1246.
#> 2 Q2 56.3 56.2 -1246.
#> 3 Q3 59.8 59.7 -1246.
#> 4 Q4 63.2 63.1 -1246.
#> 5 Q5 (least deprived) 66.8 66.7 -1246.
#>
#> -- Inequality impact --
#> # A tibble: 4 × 5
#> index pre post change pct_change
#> <chr> <dbl> <dbl> <dbl> <dbl>
#> 1 sii 18.1 18.1 1.07e-14 5.87e-14
#> 2 rii 0.304 0.305 5.31e- 4 1.74e- 1
#> 3 gini 0.0487 0.0488 8.49e- 5 1.74e- 1
#> 4 atkinson_1 0.00374 0.00376 1.32e- 5 3.52e- 1Cookson R, Griffin S, Norheim OF, Culyer AJ (2020). Distributional Cost-Effectiveness Analysis. Oxford University Press (ISBN:9780198838197).
NICE (2025). Technology Evaluation Methods: Health Inequalities (PMG36).
Love-Koh J et al. (2019). Value in Health 22(5): 518-526.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.